Acquired Amegakaryocytic ThrombocytopeniaSymptoms, Doctors, Treatments, Advances & More
Acquired Amegakaryocytic Thrombocytopenia Overview
Learn About Acquired Amegakaryocytic Thrombocytopenia
Condition 101 content is not available at this time, but we are continually updating the site. Please check back.
However, there may be experts who have treated this or similar conditions in our Find a Doctor section and research may be available in our Latest Advances section.
Manuela Germeshausen practices practicing medicine in Hannover, Germany. Ms. Germeshausen is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. She is also highly rated in 3 other conditions, according to our data. Her clinical expertise encompasses Acquired Amegakaryocytic Thrombocytopenia, Agranulocytosis, Cyclic Neutropenia, and Severe Congenital Neutropenia.
Matthias Ballmaier practices practicing medicine in Hannover, Germany. Mr. Ballmaier is rated as an Elite expert by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. He is also highly rated in 1 other condition, according to our data. His clinical expertise encompasses Acquired Amegakaryocytic Thrombocytopenia, Thrombocytopenia, Aplastic Anemia, and Paroxysmal Cold Hemoglobinuria.
USA Health Physician Billing Services LLC
Preethi Marri is a Hematologist and an Oncologist practicing medicine in Mobile, Alabama. Dr. Marri is rated as an Elite provider by MediFind in the treatment of Acquired Amegakaryocytic Thrombocytopenia. She is also highly rated in 2 other conditions, according to our data. Her clinical expertise encompasses Acquired Amegakaryocytic Thrombocytopenia, Renal Vein Thrombosis, Mesenteric Venous Thrombosis, Sickle Cell Disease, and Bone Marrow Transplant.
Summary: The objective of this study is to evaluate the efficacy of using a reduced-intensity condition (RIC) regimen with umbilical cord blood transplant (UCBT), double cord UCBT, matched unrelated donor (MUD) bone marrow transplant (BMT) or peripheral blood stem cell transplant (PBSCT) in patients with non-malignant disorders that are amenable to treatment with hematopoietic stem cell transplant (HSCT). ...
Summary: Children, adolescents, and young adults with malignant and non-malignant conditionsundergoing an allogeneic stem cell transplantation (AlloSCT) will have the stem cells selected utilizing α/β CD3+/CD19+ cell depletion. All other treatment is standard of care.